11
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Adenylate Cyclase Modulation of Ion Permeability in the Guinea Pig Cochlea: a Possible Mechanism for the Formation of Endolymphatic Hydrops

, &
Pages 667-673 | Received 05 Jul 1991, Accepted 26 Sep 1991, Published online: 08 Jul 2009
 

Abstract

The pathophysiological mechanisms leading to endolymphatic hydrops in Meniere's disease are unknown. Changes in ionic permeability of the cellular membranes between the endolymph and the perilymph, which alter the composition and osmolality of the inner ear fluid, may be a major factor in the etiology of endolymphatic hydrops. To determine the possible involvement of adenylate cyclase in the formation of endolymphatic hydrops, we measured the endolymphatic K+, Na+, CI activities (AK, ANa, ACI) and the endocochlear potential (EP) by means of ion-selective microelectrodes while inner ear adenylate cyclase was activated by perilymphatic perfusion with forskolin. We observed a large Ac increase accompanied by an EP increase during forskolin (2x 10−4 M) perfusion and a delayed AK decrease after perfusion. No measurable ANa change was observed.These results suggest that adenylate cyclase may regulate CI permeability of the endolymph-perilymph barrier and that adenylate cyclase plays a critical role in acute endolymphatic hydrops in Meniere's disease by altering the osmolarity of the endolymph.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.